Lazard Asset Management LLC Bristol Myers Squibb CO Transaction History
Lazard Asset Management LLC
- $61.8 Billion
- Q4 2024
A detailed history of Lazard Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lazard Asset Management LLC holds 379,325 shares of BMY stock, worth $20.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
379,325
Previous 679,475
44.17%
Holding current value
$20.4 Million
Previous $35.2 Million
38.99%
% of portfolio
0.03%
Previous 0.05%
Shares
46 transactions
Others Institutions Holding BMY
# of Institutions
2,729Shares Held
1.57BCall Options Held
30MPut Options Held
31.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.55 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.18 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.13 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.25 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...